Abstract Aim The “2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management
of Patients With Chronic Coronary Disease” provides an update to and consolidates new …

Several epidemiologic and toxicological studies have commonly viewed ambient fine
particulate matter (PM2. 5), defined as particles having an aerodynamic diameter of less …

Atherosclerotic cardiovascular (CV) disease (ASCVD) incidence and mortality rates are
declining in many countries in Europe, but it is still a major cause of morbidity and mortality …

The available evidence on the effects of ambient air pollution on cardiovascular diseases
(CVDs) has increased substantially. In this umbrella review, we summarized the current …

Stroke is the second highest cause of death globally and a leading cause of disability, with
an increasing incidence in developing countries. Ischaemic stroke caused by arterial …

Background Air pollution is a leading cause of mortality and morbidity worldwide. Short-term
exposure (from one hour to days) to selected air pollutants has been associated with human …

Non-communicable diseases (NCDs) are fatal for more than 38 million people each year
and are thus the main contributors to the global burden of disease accounting for 70% of …

Oxides of nitrogen (NOx) and volatile organic compounds (VOCs) released into the
atmosphere can react in the presence of solar irradiation, leading to ozone formation in the …

Abstract Fine particulate matter< 2.5 μm (PM2. 5) air pollution is the most important
environmental risk factor contributing to global cardiovascular (CV) mortality and disability …

EP AA uthor Man uscript operationalizing the PECO approach and the types of PECO
questions researchers and decision-makers can answer. We identified only limited indirect …